These findings suggest that CD8‐positive TIL density may serve as a useful predictor of MMR status, and their interaction with PD‐L1‐positive TILs could play a crucial role in treatment outcomes for MMR‐deficient UTUC. Here, CD8A is linked to renal pelvis/ureter urothelial carcinoma.